Axa’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,700
Closed -$637K 1077
2023
Q2
$637K Sell
22,700
-900
-4% -$22.3K ﹤0.01% 915
2023
Q1
$527K Sell
23,600
-12,800
-35% -$335K ﹤0.01% 955
2022
Q4
$967K Buy
+36,400
New +$1.19M ﹤0.01% 890
2022
Q3
Sell
-53,200
Closed -$1.11M 1145
2022
Q2
$1.11M Sell
53,200
-9,900
-16% -$185K ﹤0.01% 865
2022
Q1
$1.37M Buy
63,100
+50,000
+382% +$1.08M ﹤0.01% 901
2021
Q4
$364K Buy
+13,100
New +$318K ﹤0.01% 1061

Other funds holding CCRN

Axa's CCRN Position: Q3 2023 in Review

Axa sold out of Cross Country Healthcare (CCRN) in Q3 2023, closing a stake of 22,700 shares — an estimated $637K sold.

Axa first reported a position in CCRN in Q4 2021 and held it in 6 quarters. The position peaked at $1.37M in Q1 2022. 189 funds tracked by Wall St. Rank hold CCRN as of Q3 2023.

  • Axa reported no remaining Cross Country Healthcare position as of Q3 2023 after selling out during the quarter.
  • Axa sold 22,700 Cross Country Healthcare shares in Q3 2023, an estimated $637K.
  • Axa first reported a position in Cross Country Healthcare in Q4 2021 and held it in 6 quarters.
  • Axa's Cross Country Healthcare position peaked at $1.37M in Q1 2022.
  • 189 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2023.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.